Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

183 trials with published results (16%)

Research Maturity

767 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.5%

52 terminated out of 1160 trials

Success Rate

93.7%

+7.1% vs benchmark

Late-Stage Pipeline

22%

258 trials in Phase 3/4

Results Transparency

24%

183 of 767 completed with results

Key Signals

183 with results94% success52 terminated

Data Visualizations

Phase Distribution

808Total
Not Applicable (341)
Early P 1 (5)
P 1 (93)
P 2 (111)
P 3 (136)
P 4 (122)

Trial Status

Completed767
Unknown153
Recruiting85
Terminated52
Not Yet Recruiting33
Active Not Recruiting31

Trial Success Rate

93.7%

Benchmark: 86.5%

Based on 767 completed trials

Clinical Trials (1160)

Showing 20 of 20 trials
NCT03926377Phase 4CompletedPrimary

Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid

NCT07645794Not Yet Recruiting

Clinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in Chronic Kidney Disease Patients Based on MRI-FF

NCT07639619Not ApplicableNot Yet Recruiting

Robot Assisted Minimally Invasive Treatment Versus Conventional Surgery for FFP3-4 Fragility Fractures of the Pelvis in Elderly Patients

NCT04253340Not ApplicableWithdrawnPrimary

Study of a Bone Assessment Technique, Bone Mineral Analyser, Concerning the Prediction of Improvement in Bone Status After an Infusion of Zoledronic Acid in Osteoporotic Women

NCT06567054Not ApplicableActive Not Recruiting

Clinical Study to Predict the Risk of Bone Fractures With the POROUS Ultrasound Device

NCT04167163Phase 4CompletedPrimary

Abaloparatide Before Total Knee Arthroplasty

NCT07325578Not ApplicableRecruiting

U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures

NCT06811363Enrolling By InvitationPrimary

Contribution of Bone to Urine Citrate

NCT07621679Not ApplicableRecruitingPrimary

People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk

NCT07620834Not ApplicableRecruitingPrimary

Artificial Intelligence-Guided Diagnosis for High-Risk Osteoporosis Populations: A Pragmatic Randomized Clinical Trial

NCT07616401Not ApplicableRecruitingPrimary

MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis

NCT06831994Not ApplicableActive Not Recruiting

Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity

NCT07154719Phase 4Recruiting

GLP-1R Actions on Muscle and the Skeleton

NCT07584785Not ApplicableCompleted

Mediterranean Diet and Progressive Resistance Training Effects on BMD and Bone Turnover in the Elderly

NCT07611097Not ApplicableNot Yet RecruitingPrimary

Osteoporosis and Sarcopenia Prevention in Middle-Aged Population

NCT06551155RecruitingPrimary

Peripheral Mononuclear Cells to Screen, Monitor and Stratify the Population at Risk of Osteoporosis and Fractures

NCT05913219Completed

Smart Wearable Device (gaitQ): Walk Better Project

NCT05266976Not ApplicableRecruiting

Mode of Exercise and Bone Biomarkers in Older Veterans

NCT06270758RecruitingPrimary

Clinical Validation of BBCT-hip

NCT07597850Phase 2Recruiting

TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status

Scroll to load more

Research Network

Activity Timeline